Guardion Health Sciences (GHSI) said Tuesday it intends to delist its common shares from the Nasdaq Capital Market in connection with its plan of liquidation and dissolution, with the official delisting expected to be effective Oct. 21.

The company expects to pay its shareholders a liquidating dividend in an amount that is anticipated to total about $3.25 per share.

Guardion said it also plans to seek no-action relief from the US Securities and Exchange Commission "as soon as practicable" in order to indefinitely suspend its reporting obligations.

The company has named board member Mark Goldstone as interim chief executive and interim president, effective Oct. 18, succeeding CEO and President Jan Hall, who has left the company, it said.

Guardion Health shares were down nearly 43% in recent trading.

Price: 3.13, Change: -2.42, Percent Change: -43.59